Invention Grant
- Patent Title: Therapeutic uses of inhibitors of RTP801
- Patent Title (中): RTP801抑制剂的治疗用途
-
Application No.: US11207119Application Date: 2005-08-16
-
Publication No.: US07741299B2Publication Date: 2010-06-22
- Inventor: Elena Feinstein , Jorg Kaufmann , Klaus Giese
- Applicant: Elena Feinstein , Jorg Kaufmann , Klaus Giese
- Applicant Address: US CA Fremont DE Berlin
- Assignee: Quark Pharmaceuticals, Inc.,Silence Therapeutics AG
- Current Assignee: Quark Pharmaceuticals, Inc.,Silence Therapeutics AG
- Current Assignee Address: US CA Fremont DE Berlin
- Agency: Cooper & Dunham LLP
- Agent John P. White
- Priority: EP04019405 20040816
- Main IPC: A61K31/70
- IPC: A61K31/70 ; C07H21/04
Abstract:
The present invention provides novel molecules, compositions, methods and uses for treating microvascular disorders, eye diseases and respiratory conditions based upon inhibition of the RTP801 gene and/or protein.
Public/Granted literature
- US20060217329A1 Therapeutic uses of inhibitors of RTP801 Public/Granted day:2006-09-28
Information query
